PharmaCon Asia
· Singapore · Pharma
Strategic insights for pharmaceutical leaders across the Asia-Pacific market.
About the event
PharmaCon Asia brings together commercial and strategy leaders across the Asia-Pacific pharmaceutical industry — covering the commercial outlook for the region's growth markets, regulatory harmonisation under ICH, pricing and market access, generic and biosimilar competition, and digital commercial models. The conference is the leading annual gathering for pharma General Managers and Heads of Strategy operating across ASEAN, Greater China, Korea and Japan.
Who should attend
- Pharma General Managers, Asia VPs and Heads of Commercial
- Heads of Regulatory Affairs and Market Access across the region
- Strategy, business development and digital health leaders
- Investors and analysts covering Asian healthcare equities
Why attend
- Compare commercial strategy notes with peers across the region
- Track price and access policy developments in the major Asian markets
- Understand the impact of NRDL, anti-corruption and VBP reforms in China
- Hear from regulators on harmonisation and accelerated-access pathways
Agenda highlights
- Day 1: Asia-Pacific pharma outlook — growth, pricing and access
- Day 1: China deep dive — NRDL, VBP, biosimilars
- Day 2: Southeast Asia — country-by-country commercial breakdown
- Day 2: Korea, Japan, Taiwan — reimbursement and innovation pathways
- Day 3: Digital commercial models and the future of the rep
Sponsorship and partnership
Sponsorship, exhibition and partnership opportunities are available across speaking, branding and lead-generation packages. Get in touch through the event registration link to receive the sponsorship prospectus.
Registration and contact
Registration details for PharmaCon Asia will be announced. Group rates and team passes are usually available; sponsorship and exhibition opportunities can be requested directly from the organiser.